For those asking about long-term use: as a healthcare professional, I can say that for many with T2D, GLP-1s are a long-term management solution, much like other medications for chronic conditions. It's about managing health, not just a quick fix.
That's a great point. Significant weight loss can sometimes lead to a loss of muscle mass, so incorporating strength training is often recommended to maintain or rebuild muscle.
To answer MDW-to-ATL's question, it really depends on the patient's medical history and insurance coverage. Some people get it through their primary care physician, others through specialists. It's often covered for diabetes; weight loss coverage varies. Pre-authorization may be needed.
I'm really pleased with my results so far, and I sympathize with your insurance issues. I've been taking it for about a year now, and I still have quite a journey ahead of me, but I've managed to lose about 110 pounds.
SLU-PP-332 is interesting because it appears to be a triple agonist, affecting GLP-1, GIP, and glucagon receptors. It's distinct from the dual agonists we often discuss. More research is definitely needed to fully understand its potential benefits and risks.
For those considering these medications for diabetes management, remember that while they can be very effective in lowering A1C levels, some individuals may need to continue them long-term to maintain those levels. It's not necessarily a "cure", but more of a management tool.
That's a valid...